» Articles » PMID: 18480259

Growth/differentiation Factor 3 Signals Through ALK7 and Regulates Accumulation of Adipose Tissue and Diet-induced Obesity

Overview
Specialty Science
Date 2008 May 16
PMID 18480259
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Growth/differentiation factor 3 (GDF3) is highly expressed in adipose tissue, and previous overexpression experiments in mice have suggested that it may act as an adipogenic factor under conditions of high lipid load. GDF3 has been shown to signal via the activin receptor ALK4 during embryogenesis, but functional receptors in adipose tissue are unknown. In this study, we show that Gdf3(-/-) mutant mice accumulate less adipose tissue than WT animals and show partial resistance to high-fat diet-induced obesity despite similar food intake. We also demonstrate that GDF3 can signal via the ALK4-homolog ALK7 and the coreceptor Cripto, both of which are expressed in adipose tissue. In agreement with a role for ALK7 in GDF3 signaling in vivo, mutant mice lacking ALK7 also showed reduced fat accumulation and partial resistance to diet-induced obesity. We propose that GDF3 regulates adipose-tissue homeostasis and energy balance under nutrient overload in part by signaling through the ALK7 receptor.

Citing Articles

Activin E is a new guardian protecting against hepatic steatosis via inhibiting lipolysis in white adipose tissue.

Park S, Cho Y, Son S, Hur J, Kim Y, Oh H Exp Mol Med. 2025; 57(2):466-477.

PMID: 39948368 PMC: 11873131. DOI: 10.1038/s12276-025-01403-6.


Alterations in Blood and Hippocampal mRNA and miRNA Expression, Along with Fat Deposition in Female B6C3F1 Mice Continuously Exposed to Prenatal Low-Dose-Rate Radiation and Their Comparison with Male Mice.

Wang H, Tanaka I, Lau S, Tanaka S, Tan A, Tang F Cells. 2025; 14(3).

PMID: 39936965 PMC: 11816924. DOI: 10.3390/cells14030173.


Hepatic Activin E mediates liver-adipose inter-organ communication, suppressing adipose lipolysis in response to elevated serum fatty acids.

Griffin J, Buxton J, Culver J, Barnes R, Jordan E, White A Mol Metab. 2024; 78:101830.

PMID: 38787338 PMC: 10656223. DOI: 10.1016/j.molmet.2023.101830.


Activin E is a transforming growth factor β ligand that signals specifically through activin receptor-like kinase 7.

Vestal K, Kattamuri C, Koyiloth M, Ongaro L, Howard J, Deaton A Biochem J. 2024; 481(7):547-564.

PMID: 38533769 PMC: 11088876. DOI: 10.1042/BCJ20230404.


Human ACVR1C missense variants that correlate with altered body fat distribution produce metabolic alterations of graded severity in knock-in mutant mice.

Tangseefa P, Jin H, Zhang H, Xie M, Ibanez C Mol Metab. 2024; 81:101890.

PMID: 38307384 PMC: 10863331. DOI: 10.1016/j.molmet.2024.101890.


References
1.
Clouthier D, Comerford S, Hammer R . Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice. J Clin Invest. 1998; 100(11):2697-713. PMC: 508473. DOI: 10.1172/JCI119815. View

2.
Andersson O, Reissmann E, Jornvall H, Ibanez C . Synergistic interaction between Gdf1 and Nodal during anterior axis development. Dev Biol. 2006; 293(2):370-81. DOI: 10.1016/j.ydbio.2006.02.002. View

3.
McPherron A, Lee S . GDF-3 and GDF-9: two new members of the transforming growth factor-beta superfamily containing a novel pattern of cysteines. J Biol Chem. 1993; 268(5):3444-9. View

4.
Jones C, Simon-Chazottes D, Guenet J, Hogan B . Isolation of Vgr-2, a novel member of the transforming growth factor-beta-related gene family. Mol Endocrinol. 1992; 6(11):1961-8. DOI: 10.1210/mend.6.11.1480182. View

5.
McPherron A, Lee S . Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest. 2002; 109(5):595-601. PMC: 150888. DOI: 10.1172/JCI13562. View